- In February 2024, Exactech, a leader in joint replacement surgery innovations, partnered with Statera Medical to develop the world’s first smart reverse shoulder implant. This groundbreaking collaboration aims to combine Exactech's expertise in implants and instruments with Statera Medical's advanced technology. The new implant is expected to revolutionize shoulder replacement procedures with its smart, connected features
- In March 2024, Stryker (NYSE: SYK), a global leader in medical technology, announced the completion of its acquisition of SERF SAS, a French joint replacement company, from Menix. This acquisition strengthens Stryker’s portfolio in the joint replacement market. It is expected to enhance Stryker's offerings and expand its presence in the global orthopedic sector
- In September 2023, HippoFi, Inc. announced a strategic partnership with Zimmer Biomet to revolutionize the spinal biologics sector. The collaboration aims to launch an innovative synthetic biomaterial designed to promote bone growth, set for release in 2024 under HippoFi's biologic subsidiary, PUR Biologics. Additionally, HippoFi/PUR secured FDA 510(K) clearance for their ActiveOrbTM technology and obtained an exclusive global license from Zimmer Biomet for the spinal market
- In 2021, Smith & Nephew (UK) acquired Integra Life Sciences' Extremity Orthopedics business to enhance its product offerings in shoulder, upper, and lower extremities. This strategic acquisition aimed to broaden Smith & Nephew's portfolio in orthopedic solutions. It reflects the company's commitment to strengthening its position in the global extremities market
- In 2021, Zimmer Biomet (US) completed the spinoff of its spine and dental businesses into a new publicly traded company, ZimVie Inc. ("ZimVie"). This strategic move was designed to sharpen the focus of both Zimmer Biomet and ZimVie on meeting the specific needs of patients and customers. The transaction aimed to maximize value for stockholders by allowing both companies to concentrate on their core areas of expertise
Frequently Asked Questions
The market is segmented based on Global Bone Cement and Glue Market Segmentation, By Type (Bone Cement and Bone Glue), Application (Arthroplasty, Total Knee Arthroplasty, Total Hip Arthroplasty, Total Shoulder Arthroplasty, Kyphoplasty, and Vertebroplasty), End-User (Hospitals, Ambulatory Surgical Centers, and Clinics) – Industry Trends and Forecast to 2031
.
The Global Bone Cement Glue Market size was valued at USD 449.29 USD Billion in 2023.
The Global Bone Cement Glue Market is projected to grow at a CAGR of 5.45% during the forecast period of 2024 to 2031.
The major players operating in the market include - 3M, BSN medical, Stryker, Zimmer Biomet, Heraeus Holding, Smith & Nephew, DJO Global, Medtronic, Globus Medical, Johnson & Johnson Services , Arthrex , aap Implantate AG, Exactech , Teknimed, CryoLife, Cardinal Health, Tecres SpA, Orthofix Medical ,-.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
